1. Identification of two glioblastoma-associated stromal cell subtypes with different carcinogenic properties in histologically normal surgical margins

   • Anne Clavreul
   • Amandine Etcheverry
   • Philippe Menei

   Laboratory Investigation 13 December 2014 Pages: 1 - 10

   

2. Chloroquine potentiates temozolomide cytotoxicity by inhibiting mitochondrial autophagy in glioma cells

   • Yusuke S. Hori
   • Ryusuke Hosoda
   • Atsushi Kuno

   Laboratory Investigation 21 December 2014 Pages: 11 - 20

   

3. Olanzapine inhibits proliferation, migration and anchorage-independent growth in human glioblastoma cell lines and enhances temozolomide’s antiproliferative effect

   • Georg Karpel-Massler
   • Richard Eric Kast
   • Marc-Eric Halatsch

   Laboratory Investigation 19 December 2014 Pages: 21 - 33

   

4. Phosphodiesterase type 5 inhibitor Tadalafil increases Rituximab treatment efficacy in a mouse brain lymphoma model

   • Rong Wang
   • Wenli Chen
   • Ying Mao

   Laboratory Investigation 19 December 2014 Pages: 35 - 42

   

5. High expression of CXCR3 is an independent prognostic factor in glioblastoma patients that promotes an invasive phenotype

   • Yi Pu
   • Shouwei Li
   • Lihua Sun

   Laboratory Investigation 20 December 2014 Pages: 43 - 51

   

6. Characterizing the peritumoral brain zone in glioblastoma: a multidisciplinary analysis

   • Jean-Michel Lemée
   • Anne Clavreul
   • Philippe Menei

   Laboratory Investigation 06 January 2015 Pages: 53 - 61

   

7. Neuropeptides of the VIP family inhibit glioblastoma cell invasion

   • Stéphanie Cochaud
   • Annie-Claire Meunier
   • Corinne Chadéneau

   Laboratory Investigation 07 January 2015 Pages: 63 - 73

   

8. Human recombinant arginase I (Co)-PEG5000 [HuArgI (Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human glioblastoma cells

   • Oula Khoury
   • Noura Ghazale
   • Ralph J. Abi-Habib

   Laboratory Investigation 08 January 2015 Pages: 75 - 85

   

9. p-CREB expression in human meningiomas: correlation with angiogenesis and recurrence risk

   • Valeria Barresi
   • Giovanni Branca
   • Giovanni Tuccari

   Laboratory Investigation 07 January 2015 Pages: 87 - 95

   

10. HFE polymorphisms affect survival of brain tumor patients

    • Sang Y. Lee
    • Becky Slagle-Webb
    • James R. Connor

    Clinical Study 10 December 2014 Pages: 97 - 104

    

11. Involvement of the neural stem cell compartment by pediatric and adult gliomas: a retrospective review of 377 cases

    • James C. Marsh
    • Stewart Goldman
    • Jason Fangusaro

    Clinical Study 11 December 2014 Pages: 105 - 110

    

12. Efficacy and patient-reported outcomes with dose-intense temozolomide in patients with newly diagnosed pure and mixed anaplastic oligodendroglioma: a phase II multicenter study

    • Manmeet S. Ahluwalia
    • Hao Xie
    • David M. Peereboom

    Clinical Study 23 December 2014 Pages: 111 - 119

    

13. LINAC-based stereotactic radiosurgery to the brain with concurrent vemurafenib for melanoma metastases

    • Kamran A. Ahmed
    • Jessica M. Freilich
    • Nikhil G. Rao

    Clinical Study 18 December 2014 Pages: 121 - 126

    

14. Examining perceived cancer risk among patients with neurofibromatosis type 1

    • Elyse R. Park
    • Kelly B. Smith
    • Scott R. Plotkin

    Clinical Study 06 January 2015 Pages: 127 - 133

    

15. Phase II trial of hypofractionated intensity-modulated radiation therapy combined with temozolomide and bevacizumab for patients with newly diagnosed glioblastoma

    • Douglas E. Ney
    • Julie A. Carlson
    • Changhu Chen

    Clinical Study 19 December 2014 Pages: 135 - 143

    

16. Impact of bevacizumab administered dose on overall survival of patients with progressive glioblastoma

    • Victor A. Levin
    • Nancy D. Mendelssohn
    • David M. Chen

    Clinical Study 11 January 2015 Pages: 145 - 150

    

17. Feasibility of fluorescence-guided resection of recurrent gliomas using five-aminolevulinic acid: retrospective analysis of surgical and neurological outcome in 58 patients

    • Anne-Katrin Hickmann
    • Minou Nadji-Ohl
    • Nikolai J. Hopf

    Clinical Study 04 January 2015 Pages: 151 - 160

    

18. Prospective longitudinal evaluation of emotional and behavioral functioning in pediatric patients with low-grade glioma treated with conformal radiation therapy

    • Victoria W. Willard
    • Heather M. Conklin
    • Thomas E. Merchant

    Clinical Study 09 January 2015 Pages: 161 - 168

    

19. Pediatric tectal plate gliomas: a review of clinical outcomes, endocrinopathies, and neuropsychological sequelae

    • David Gass
    • Mariko Dewire
    • Trent R. Hummel

    Clinical Study 13 January 2015 Pages: 169 - 177

    

20. Prognosis of glioblastoma with faint MGMT methylation-specific PCR product

    • Chih-Yi Hsu
    • Hsiang-Ling Ho
    • Donald Ming-Tak Ho

    Clinical Study 10 January 2015 Pages: 179 - 188

    

21. Temozolomide and pasireotide treatment for aggressive pituitary adenoma: expertise at a tertiary care center

    • Filippo Ceccato
    • Giuseppe Lombardi
    • Carla Scaroni

    Clinical Study 03 January 2015 Pages: 189 - 196

    

22. Evaluation of RANO response criteria compared to clinician evaluation in WHO grade III anaplastic astrocytoma: implications for clinical trial reporting and patterns of failure

    • Tomas Kazda
    • John G. Hardie
    • Nadia N. Laack

    Clinical Study 11 January 2015 Pages: 197 - 203

    

23. Predicting early brain metastases based on clinicopathological factors and gene expression analysis in advanced HER2-positive breast cancer patients

    • Renata Duchnowska
    • Jacek Jassem
    • Sunil Badve

    Clinical Study Open access 06 January 2015 Pages: 205 - 216

    

24. Anaplastic oligoastrocytoma: is molecular stratification based on 1p/19q status alone appropriate?

    • Yingjie Zou
    • Harrison Xiao Bai
    • Li Yang

    Letter to the Editor 03 January 2015 Pages: 217 - 218